Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: Claim interpretation if preamble equates to state of the art

When interpreting a patent claim, it must be taken into account that a patent's doctrine seeks to distinguish itself from the state of the art described in it. If the specification equates to known prior art with the claim's preamble, the features of the characterising portion of the patent shall – in case of doubt – not be regarded as being understood according to features which are found in the state of the art from which they currently should have been distinguished. (Guiding principle of the Court)

PatG § 14; EPÜ Art. 69; BGH X ZR 16/17 (BPatG) – Scheinwerferbelüftungssystem

The defendant was the proprietor of European patent 0 764 811, relating to headlamps of motor vehicles with a ventilation system, which had meanwhile expired. An action for annulment will continue to be admissible owing to the fact that a declaration of invalidity of the patent in dispute opened up the possibility for the plaintiff to bring an action for restitution against its judgment.

The description of the patent in dispute was adapted in the course of the grant procedure to note that the expert was aware of a ventilation system, according to the preamble of independent patent claim 1 from a French patent application belonging to the state of the art. In the course of the grant procedure claim 1 was changed into a two-part form. The characteristic part of claim 1 of the patent in dispute provides, inter alia, that the ventilation system forms a labyrinth, with a twofold change of direction of the ventilation path.

The plaintiff asserts that such a labyrinth, with a twofold change of direction, is shown in the French patent application cited, which is why the subject matter of the patent at issue is not patentable owing to a lack of novelty, or at least due to a lack of inventive step. The BPatG dismissed the request.

The nullity appeal was directed against this judgement and the plaintiff continued to seek the full nullity of the patent in dispute.

The BGH rejected the appeal.Consequently, in nullity proceedings a novelty attack based on prior art cited in the patent specification might, in case of doubt, not be successful if the prior art in the patent is equated with the preamble of the claim as explained in this decision. On the other hand, a restrictive interpretation of the claims can be made in equivalent cases for infringement proceedings


Volker Tegeder

Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64

more from across site and ros bottom lb

More from across our site

Shira Perlmutter, US Register of Copyrights, discussed the copyright office's role in generative AI policy during a House of Representatives hearing
The award marks one of the highest-ever damages received by a foreign company in a trademark infringement suit in China
Two orders denying public access to the documents have reignited a debate over a lack of transparency at the new court
Rouse’s new chief of operations and the firm’s CEO tell Managing IP why they think private equity backing will help it conquer Europe
Brian Landry, partner at Saul Ewing, reveals how applicants can prosecute patent applications in the wake of the Federal Circuit's In re Cellect ruling
Ronelle Geldenhuys of Australia’s Foundry IP considers the implications complex computer technologies such as AI have on decision-making
Bertha Ho, who helped the Hush Puppies owner with the sale of its IP rights in China and Hong Kong SAR, explains how to navigate complex transactions in the region
Online storytelling platform Humans of Bombay isn’t wrong for trying to protect its copyright, but it could have handled its dispute better
We have started accepting submissions from in-house counsel and teams for the 19th annual Managing IP Awards programme
Patient groups and generics makers may have to bear the brunt of India’s latest attempt at patent reform